국내 제약기업의 연구개발비 및 마케팅 비용이 기업성과에 미치는 영향 연구

• Published in: Yaghag-hoi-ji Vol. 63; no. 4; pp. 204 - 213
• Main Authors: 정재은(Jae Eun Jung), 강민구(Minku Kang), 방준석(Joon Seok Bang)
• Format: Journal Article
• Language: Korean
• Published: The Pharmaceutical Society Of Korea 30.08.2019; 대한약학회
• Subjects: 약학; company performance; operating profit; sales growth rate; Pharmaceutical company; R&D investment; marketing expense
• ISSN: 0377-9556; 2383-9457
• DOI: 10.17480/psk.2019.63.4.204

The purpose of this study was to investigate the effect of R&D investment and marketing expenses on theperformance of the Korean pharmaceutical companies. The top-ranked forty companies in Korea were selected and the 6-year-long data were analyzed to obtain the correlations among R&D intensity, marketing expenses, growth rate, operatingprofitability. In addition, the differences between innovative and non-innovative pharmaceutical companies were alsoexamined. Both the amount and the ratio of R&D investment over sales activities were significantly higher in theinnovative pharmaceutical companies compared with the non-innovative pharmaceutical companies. In these competitivecircumstances, R&D investment is indispensable for the sustainable growth in pharmaceutical companies. In conclusion,Korean pharmaceutical companies as well as government bodies should focus on more intensive and strategic R&Dactivities to increase the capabilities for developing innovative new products and future prosperity. KCI Citation Count: 0